Mitochondrial genome-targeting nucleic acids are promising therapeutic candidates for treating mitochondrial diseases. To date, a number of systems for delivering genetic information to the cytosol and the nucleus have been reported, and several successful gene therapies involving gene delivery targeted to the cytosol and the nucleus have been reported. However, much less progress has been made concerning mitochondrial gene delivery systems, and mitochondrial gene therapy has never been achieved. Here, we report on the mitochondrial delivery of an antisense RNA oligonucleotide (ASO) to perform mitochondrial RNA knockdown to regulate mitochondrial function. Mitochondrial delivery of the ASO was achieved using a combination of a MITO-Porter system, which contains mitochondrial fusogenic lipid envelopes for mitochondrial delivery via 
Introduction
Small interfering RNA (siRNA) is frequently used to achieve specific knockdown of target mRNA [1] . Although recent studies have addressed the component of the RNA-induced silencing complex in mitochondria, applications of siRNA to mitochondria have not been reported [2] . On the other hand, this unique organelle possesses not only protein-coding mRNA transcribed from mitochondrial DNA (mtDNA) but also non-coding RNAs such as tRNA, rRNA, and microRNA (miRNA) [3] [4] [5] [6] [7] [8] . It has been reported that miRNAs have the potential to regulate mitochondrial gene expression via a post-transcriptional pathway such as mitochondrial RNA degradosomes [9] [10] [11] [12] . Thus, the knockdown of mitochondrial RNA via the mitochondrial delivery of antisense RNA oligonucleotide (ASO) would be expected to contribute to the development of a mitochondrial therapeutic approach and a more complete understanding of the post-transcriptional regulation.
System for nucleic acids targeted to the cytosol and nucleus have been reported, while less efforts have been expended on mitochondrial delivery systems [1, 13, 14] . Weissig et al reported that DQAsome, the mitochondriotropic nanocarrier [15, 16] , was useful in altering mitochondrial gene expression by virtue of delivering a mini-mitochondrial genome to mitochondria [16] .
However, a universal carrier has not yet been developed for mitochondrial matrix delivery, although they reported that an approach using a cationic nanocarrier such as DQAsome could be useful in terms of interacting with mitochondria. Seibel et al reported that oligo DNA (ODN) and a peptide nucleic acid (PNA) covalently conjugated with the mitochondrial targeting signal peptide (MTS) can be introduced into isolated mitochondria [17, 18] . With the help of a device the cytoplasmic delivery, MTS-conjugated PNA was imported into mitochondria in cells. This method could be a viable strategy for the genetic modification of mitochondria [18] . We recently developed a MITO-Porter system, mitochondrial delivery system via mitochondrial outer membrane fusion [19, 20] . We applied the MITO-Porter system to mitochondrial genome targeting, such as the specific digestion of mtDNA by delivering encapsulated DNase I [21, 22] .
In this study, we report on mitochondrial ASO delivery using an R8/GALA-modified MITO-Porter, and validation of mitochondrial RNA knockdown to control mitochondrial function.
As shown in Figure 1A , the R8/GALA-modified MITO-Porter is surface-modified with a high density of octaarginine (R8), which permits the particle to be efficiently internalized by cells via macropinocytosis (1st step) [23] . Once inside the cell, the carrier escapes from the endosome into the cytosol with the assistance of GALA, a pH-sensitive membrane fusogenic peptide (2nd step) [24] [25] [26] . The carrier then binds to mitochondria via electrostatic interactions with R8 (3rd step). In this experiment, we packaged the D-arm modified ASO in the carrier. D-arm is a D stem-loop import signal of tRNA Tyr (GUA) with the sequence UGGUAGAGC, and is efficiently imported into the mitochondrion of Leishmania, a kinetoplastid protozoan [27] . Oligo nucleic acids constituting D-arm or its analogues can also be imported into the mitochondrial matrix through the mitochondrial inner membrane in isolated mitochondria [28, 29] . Thus, it was expected that Darm modified ASO encapsulated in the R8/GALA-modified MITO-Porter would facilitate mitochondrial matrix delivery. One possibility is that the MITO-Porter delivers the D-arm ASO to the mitochondrial intermembrane space after fusion with the outer membrane, and it is then imported into the mitochondrial matrix via the D-arm import machinery (upper part in Figure 1B ).
An alternate another possibility is that the carriers directly introduce ASO into the mitochondrial matrix via step-wise membrane fusion on the contact sites of the outer and inner mitochondrial membranes (lower part in Figure 1B ).
We first constructed R8/GALA-modified MITO-Porter (D-arm ASO [COX II]), where Darm modified ASO which targeted mitochondrial mRNA that codes for cytochrome c oxidase subunit II (COX II) was packaged. COX II is one of mitochondrial proteins that make up complex IV of the respiratory chain related to maintaining the mitochondrial membrane potential. If the knockdown of the COX II mRNA was successful, the expression levels of the target mitochondrial protein would be decreased, followed by a decrease in mitochondrial functions such as maintaining membrane potential ( Figure 1C ). The knockdown of target mitochondrial mRNA and protein were then evaluated to demonstrate the efficiency of mitochondrial ASO delivery using the R8/GALAmodified MITO-Porter using quantitative reverse transcription PCR (qRT-PCR) and immunostaining. Moreover, we evaluated the mitochondrial membrane potential to investigate the effect of the mitochondrial ASO transfection on mitochondrial function.
Materials and methods

Chemicals and materials
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) and sphingomyelin (SM) were purchased from Avanti Polar lipids (Alabaster, AL). Cholesteryl hemisuccinate (CHEMS) were purchased from Sigma (St Louis, MO). Stearylated R8 and Cholesterol-GALA were obtained from KURABO Industries (Osaka, Japan Particle diameters and polydispersity index (PDI) as an indicator of the particle-size distribution were measured using a dynamic light scattering (DLS) method (Zetasizer Nano ZS;
Malvern Instruments, Worcestershire, UK). Samples were prepared in 10 mM HEPES buffer at 25°C and the values of particle diameters are shown in the form of volume distribution. The ξ-potentials of samples were also determined in 10 mM HEPES buffer at 25°C using a Zetasizer Nano ZS.
Cell cultures
HeLa cells were maintained in complete medium which is DMEM supplemented with 10% FBS, penicillin (100 units/mL), and streptomycin (100 μg/mL). The cells were cultured under an atmosphere of 5% CO2/air at 37°C. One day before transfection, the HeLa cells were seeded on a plates or dishes for each experiment. Immediately before transfection, the medium was replaced to serum-free medium, DMEM unsupplemented with antibiotics. We confirmed the absence of contaminating DNA when this RT-PCR assay was peformed.
Quantification of target mitochondrial mRNA levels
Gel images of RT-PCR detection showed that the target DNA bands appeared in the case of reverse transcription (RT(+)) (lanes 2,3 in Figure S1 ) and they disappeared in the absence of reverse transcription (RT(-)) (lanes 4,5 in Figure S1 ). We also observed the same tendency when qRT-PCR was performed (data not shown). It was confirmed that RT-PCR with specific primers for mitochondrial mRNA coding COX II could detect single bands coresponding to the target mRNA (lanes 2,3 in Figure S1 ).
Intracellular observation of R8/GALA-modified MITO-Porter encapsulating fluorescent labeled ASOs using confocal laser scanning microscopy (CLSM)
The R8 
Statistical Analysis
The diameters, PDIs, and ξ-potentials of the carriers were measured. Each of the values shown in Table 1 (n=3) represent the mean ± S.D. Mitochondrial mRNA knockdown by the R8/GALA-modified MITO-Porter was evaluated. Each value shown in Figure 2 represents the mean ± SEM (n=3-4). Statistical significances between non treatment and others were calculated by one-way ANOVA, followed by the Dunnett test. Relative COX II/SDHA protein expression levels of each one cell were evaluated based on the images in Figure 4 . In Figure 5 , the values for were calculated by one-way ANOVA, followed by Dunnett test. Levels of p < 0.05 were considered to be significant.
RESULTS
Construction of R8/GALA-modified MITO-Porter and evaluation of mitochondrial RNA knockdown
We evaluated the knockdown of mitochondrial mRNA, following the mitochondrial ASO delivery by R8/GALA-modified MITO-Porter. In this experiment, we used the D-arm modified antisense 2′-OMe RNA which targeted COX II (D-arm ASO [COX II]) (see Table S1 for details).
We prepared R8/GALA-modified MITO-Porter encapsulating D-arm ASO [COX II] and D-armmodified 2′-OMe RNA non-targeting COX II (D-arm Mock). The diameter, PDI (an indicator of particle-size distribution) and the ζ potential of the carriers are listed in Table 1 . The envelope of the carriers had a mitochondria-fusogenic composition [DOPE/SM/stearylated R8] [21, 22] equipped with Chol-GALA. As shown in Table 1 
Intracellular observation of the R8/GALA-modified MITO-Porter
To verify that mitochondrial RNA knockdown was the result of the delivery of ASO to mitochondria by the R8/GALA-modified MITO-Porter, we observed the intracellular trafficking of the carrier using CLSM (Figure 3 ). In this experiment, the Cy-5 labeled D-arm ASO [COX II]
was encapsulated in the R8/GALA-modified MITO-Porter. In the case of the R8/GALA-modified MITO-Porter, numerous green and some yellow dots were observed in cells ( Figures 3A, 3C ),
indicating that the Cy5-labeled ASOs (pseudo green color) were mainly localized in the cytosol and some ASOs were localized in red-stained mitochondria. To check endosomal escape efficiency, we observed the intracellular trafficking of the carriers after staining the acidic compartment blue ( Figures 3B, 3C ). The findings show that most of the green dots were observed to be outside the acidic compartment, suggesting that the carriers had been released from the endosomes to the cytosol. In the case of the R8-modified MITO-Porter without GALA, numerous cyan colored dots 
Evaluation of protein knockdown by R8/GALA-modified MITO-Porter
We evaluated the variation in expression of target proteins after the mitochondrial delivery 
Visualization of mitochondrial membrane potential after mitochondrial ASO delivery by R8/GALA-modified MITO-Porter
We evaluated the effect of ASO-mediated mitochondrial mRNA knockdown on the mitochondrial membrane potential. JC-1 is a cationic dye that exhibits a potential-dependent accumulation in mitochondria, as florescence emission shift from green (monomeric form) to red (aggregated form) [31] . 
Discussion
The findings reported herein provide a demonstration of the successful mitochondrial delivery and knockdown of target mRNA using a combination of a MITO-Porter system and Darm ASO [COX II]. As mentioned in the introduction, the D-arm used in this study functions as a mitochondrial tRNA import signal and this sequence is imported into the mitochondrial matrix in mitochondria of Leishmania [27] [28] [29] . Thus, it would be expected that the D-arm would assist mitochondrial matrix delivery, even in human cells, as shown in Figure 1B . While, until decade ago, it was generally thought that tRNA is not imported into human mitochondria from the cytoplasm, although the mitochondrial import of small RNAs had been demonstrated in a number of organisms. Tarassov and co-workers recently reported that some yeast tRNA derivatives can be imported into isolated human mitochondria [32] . They also showed that yeast tRNA Lys derivatives expressed in human cells are partially imported into mitochondria, and demonstrated the functionality of imported tRNAs in human mitochondria [33] . More recently, Rubio et al. reported that human mitochondria possess a similar active tRNA import system in vivo as well as other eukaryotes, and the import system is different from the protein import system [34] .
Intracellular observations using CLSM permitted us to confirm that the R8/GALAmodified MITO-Porter succeeded in delivering cargoes to mitochondria in living cells ( Figures   3A-C) . To achieve this mitochondrial delivery, multiple processes including cellular uptake, endosomal escape and mitochondrial targeting need to be regulated, as shown in Figure 1A . We concluded that R8 and GALA were effective in regulating the intracellular trafficking to deliver the cargo to the target organelle. R8 functions as a cell-penetrating device that functions via macropinocytosis and a mitochondria-targeting peptide via electrostatic interaction. A previous report showed that the R8-modified MITO-Porter (conventional type) was efficiently internalized and escaped from macropinosomes to the cytosol with the encapsulated compounds being maintained intact, with the MITO-Porter being ultimately bound to mitochondria via electrostatic interactions [19, 20] . However, a detailed analysis of intracellular trafficking of R8-modified MITO-Porter revealed that the most of the carriers were localized in acidic compartments (endosomes and lysosomes), although the carriers were efficiently taken up by cells [21, 22] . The CLSM images shown in Figure S3 also indicate that the R8-modified MITO-Porter without GALA was mainly localized in acidic compartments. In this study, GALA was used to assist the carriers to escape from endosomes. Previously, it was reported that the inclusion of GALA in the surface of liposomes promoted the destabilization of the endosomal membranes, thus enhancing endosomal escape [25] . Intracellular observations shown in Figures 3A-C and Figure S3 show that the R8/GALA-modified MITO-Porter had a higher endosomal escape efficiency than that of the R8-modified MITO-Porter (conventional type), resulting in higher mitochondrial targeting.
In the CLSM analysis, the R8/GALA-modified MITO-Porter (D-arm ASO [COX II]) was determined to be localized in the cytosol and mitochondria in the form of dots and not a diffuse form ( Figures 3A-C) , as previously reported [19, 20] . protons out of the matrix and ultimately driving ATP synthesis [36] . mtDNA-encoded subunits, COX I, COX II, and COX III, make up the catalytic core of complex IV [37, 38] . Interestingly, it was reported that mitochondria possess miRNA and that miR-181c regulates the gene expression of COX I by currently unknown post-transcriptional events [39] . An overexpression of miR-181c
decreases the mRNA levels of COX I, resulting in an imbalance among the mitochondrially encoded subunits in complex IV, which has an effect on mitochondrial function (ex, an increased production of reactive oxygen species) [39] . 
Conclusion
Our finding constitutes the first report to demonstrate that the nanocarrier-mediated mitochondrial genome targeting of antisense RNA effects mitochondrial function. While, we were unable to determine whether this carrier would be able to achieve the specific knockdown of target mRNA, because the expression levels of all mitochondrial mRNA were not quantified. Further experiments including the validation of off-target effects and advanced function analysis will be required to establish a high-performance methodology for controlling mitochondrial gene expression and function. Future studies will involve detailed investigations of mitochondrial knockdown using a MITO-Porter system in conjunction with experts in the field of mitochondrial molecular biology. Table S1 for the detail). Another possibility is that the carrier directly introduces the D-arm ASO into the mitochondrial matrix through OM and IM on the contact sites of the mitochondrial membranes (lower part). IM, inner membrane; IMS, intermembrane space; OM, outer membrane. 
